221 results
Page 3 of 12
425
zh4usfs5gcw
30 Mar 23
Business combination disclosure
8:51am
425
EX-2.1
b9eautndb487mkz
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-99.2
evpzrn
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-2.1
2p9jxyb t0naoj5b5hm3
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
09df8e b7
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
DEFA14A
8yhw ovqmrbisb
16 Dec 22
Additional proxy soliciting materials
5:16pm
8-K
EX-10.1
x3nvdc
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
PRRN14A
di9bx4
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFC14A
y5k56tsv6yv4huwe7
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
tceg1mcs
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
UPLOAD
tdr 0ufec8
30 Nov 22
Letter from SEC
12:00am
PRER14A
iik0 1n36
28 Nov 22
Preliminary revised proxy
5:17pm
CORRESP
zzaynin9s 3f06s
28 Nov 22
Correspondence with SEC
12:00am
PREC14A
v5cmtd8b
23 Nov 22
Preliminary proxy with contested solicitation
11:26am
UPLOAD
ibmgmjh3l58kctx
22 Nov 22
Letter from SEC
12:00am
PREC14A
63hbd3
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
DFAN14A
8exjw1n2a6x bast
18 Nov 22
Additional proxy materials by non-management
11:02am
8-K
ur6yy7
10 Nov 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:00pm